Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Restoring repolarization in LQT3.

× No keyword cloud information.

13 in total

1. Biophysical characterization of the new human ether-a-go-go-related gene channel opener NS3623 [N-(4-bromo-2-(1H-tetrazol-5-yl)-phenyl)-N'-(3'-trifluoromethylphenyl)urea].

Authors: Rie Schultz Hansen; Thomas Goldin Diness; Torsten Christ; Erich Wettwer; Ursula Ravens; Søren-Peter Olesen; Morten Grunnet
Journal: Mol Pharmacol Date: 2006-07-06 Impact factor: 4.436

2. Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome.

Authors: Matteo Vatta; Michael J Ackerman; Bin Ye; Jonathan C Makielski; Enoh E Ughanze; Erica W Taylor; David J Tester; Ravi C Balijepalli; Jason D Foell; Zhaohui Li; Timothy J Kamp; Jeffrey A Towbin
Journal: Circulation Date: 2006-10-23 Impact factor: 29.690

3. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias.

Authors: P J Schwartz; S G Priori; C Spazzolini; A J Moss; G M Vincent; C Napolitano; I Denjoy; P Guicheney; G Breithardt; M T Keating; J A Towbin; A H Beggs; P Brink; A A Wilde; L Toivonen; W Zareba; J L Robinson; K W Timothy; V Corfield; D Wattanasirichaigoon; C Corbett; W Haverkamp; E Schulze-Bahr; M H Lehmann; K Schwartz; P Coumel; R Bloise
Journal: Circulation Date: 2001-01-02 Impact factor: 29.690

4. The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge.

Authors: S G Priori; C Napolitano; P J Schwartz; R Bloise; L Crotti; E Ronchetti
Journal: Circulation Date: 2000-08-29 Impact factor: 29.690

5. Pharmacological targeting of long QT mutant sodium channels.

Authors: D W Wang; K Yazawa; N Makita; A L George; P B Bennett
Journal: J Clin Invest Date: 1997-04-01 Impact factor: 14.808

6. Antiarrhythmic effect of IKr activation in a cellular model of LQT3.

Authors: Jonas Goldin Diness; Rie Schultz Hansen; Jakob Dahl Nissen; Thomas Jespersen; Morten Grunnet
Journal: Heart Rhythm Date: 2008-10-17 Impact factor: 6.343

7. Molecular mechanism for an inherited cardiac arrhythmia.

Authors: P B Bennett; K Yazawa; N Makita; A L George
Journal: Nature Date: 1995-08-24 Impact factor: 49.962

8. Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action.

Authors: Sandra Fredj; Kevin J Sampson; Huajun Liu; Robert S Kass
Journal: Br J Pharmacol Date: 2006-05 Impact factor: 8.739

9. Effect of pacing and mexiletine on dispersion of repolarisation and arrhythmias in DeltaKPQ SCN5A (long QT3) mice.

Authors: Larissa Fabritz; Paulus Kirchhof; Michael R Franz; Dieter Nuyens; Tom Rossenbacker; Alexander Ottenhof; Wilhelm Haverkamp; Günter Breithardt; Edward Carmeliet; Peter Carmeliet
Journal: Cardiovasc Res Date: 2003-03-15 Impact factor: 10.787

10. Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy.

Authors: P J Schwartz; S G Priori; E H Locati; C Napolitano; F Cantù; J A Towbin; M T Keating; H Hammoude; A M Brown; L S Chen; T J Colatsky
Journal: Circulation Date: 1995-12-15 Impact factor: 29.690